Lipella Pharmaceuticals Inc. (LIPO): EPS (Diluted)

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-8, first reflected in a filing dated 2024-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

-$4.79
Year ended 2024-12-31
2021-12-31: -$0.552022-12-31: -$0.642023-12-31: -$6.162024-12-31: -$4.79-$4.79
2021-12-31 EPS (Diluted) (USD per share) 2024-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Diluted)Change YoYSource filing
2024-12-31-$4.79n/m2025-03-28, From 2024-01-01
2023-12-31-$6.16n/c2025-03-28, From 2023-01-01
2022-12-31-$0.64n/m2024-02-27, From 2022-01-01
2021-12-31-$0.55n/a2023-03-31, From 2021-01-01